Product NDC: | 16571-302 |
Proprietary Name: | Guaifenesin |
Non Proprietary Name: | Guaifenesin and Codeine Phosphate |
Active Ingredient(s): | 10; 100 mg/5mL; mg/5mL & nbsp; Guaifenesin and Codeine Phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16571-302 |
Labeler Name: | Pack Pharmaceuticals LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20090922 |
Package NDC: | 16571-302-16 |
Package Description: | 473 mL in 1 BOTTLE (16571-302-16) |
NDC Code | 16571-302-16 |
Proprietary Name | Guaifenesin |
Package Description | 473 mL in 1 BOTTLE (16571-302-16) |
Product NDC | 16571-302 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Guaifenesin and Codeine Phosphate |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20090922 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Pack Pharmaceuticals LLC |
Substance Name | CODEINE PHOSPHATE; GUAIFENESIN |
Strength Number | 10; 100 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes |